These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 24292963)
1. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Hensing T; Chawla A; Batra R; Salgia R Adv Exp Med Biol; 2014; 799():85-117. PubMed ID: 24292963 [TBL] [Abstract][Full Text] [Related]
2. Targeted therapies for small cell lung cancer: Where do we stand? Arcaro A Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer. Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033 [TBL] [Abstract][Full Text] [Related]
4. Targeted Therapy for Non-Small Cell Lung Cancer. Noor ZS; Cummings AL; Johnson MM; Spiegel ML; Goldman JW Semin Respir Crit Care Med; 2020 Jun; 41(3):409-434. PubMed ID: 32450595 [TBL] [Abstract][Full Text] [Related]
5. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917 [TBL] [Abstract][Full Text] [Related]
6. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Niederst MJ; Sequist LV; Poirier JT; Mermel CH; Lockerman EL; Garcia AR; Katayama R; Costa C; Ross KN; Moran T; Howe E; Fulton LE; Mulvey HE; Bernardo LA; Mohamoud F; Miyoshi N; VanderLaan PA; Costa DB; Jänne PA; Borger DR; Ramaswamy S; Shioda T; Iafrate AJ; Getz G; Rudin CM; Mino-Kenudson M; Engelman JA Nat Commun; 2015 Mar; 6():6377. PubMed ID: 25758528 [TBL] [Abstract][Full Text] [Related]
7. Personalized targeted therapy for lung cancer. Wu K; House L; Liu W; Cho WCS Int J Mol Sci; 2012; 13(9):11471-11496. PubMed ID: 23109866 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients. Tian HX; Zhang XC; Yang JJ; Guo WB; Chen ZH; Wang Z; Wu YL Lung Cancer; 2017 Dec; 114():90-95. PubMed ID: 29173772 [TBL] [Abstract][Full Text] [Related]
9. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285 [TBL] [Abstract][Full Text] [Related]
10. Personalized therapy on the horizon for squamous cell carcinoma of the lung. Kim HS; Mitsudomi T; Soo RA; Cho BC Lung Cancer; 2013 Jun; 80(3):249-55. PubMed ID: 23489560 [TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398 [TBL] [Abstract][Full Text] [Related]
13. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. Li T; Kung HJ; Mack PC; Gandara DR J Clin Oncol; 2013 Mar; 31(8):1039-49. PubMed ID: 23401433 [TBL] [Abstract][Full Text] [Related]